![]() |
Volumn 16, Issue 3-4, 2007, Pages 137-158
|
Cumulative updating of approved biopharmaceuticals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVATA;
AGALSIDASE BETA;
ALEFACEPT;
ALTEPLASE;
ARCITUMOMAB TC 99M;
BETA1A INTERFERON;
BEVACIZUMAB;
CETUXIMAB;
CHOLERA VACCINE;
ETANERCEPT;
EXENDIN 4;
GAMMA1B INTERFERON;
HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE;
HEPATITIS A HEPATITIS B VACCINE;
HEPATITIS B VACCINE;
IDURONATE 2 SULFATASE;
IMIGLUCERASE;
INSULIN GLULISINE;
INTERFERON BETA SERINE;
LARONIDASE;
PARATHYROID HORMONE[1-34];
RASBURICASE;
RECOMBINANT ANTITHROMBIN III;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT BLOOD CLOTTING FACTOR 9;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT HEPATITIS B VACCINE;
RECOMBINANT HUMAN INSULIN;
SALCATONIN;
TASONERMIN;
TOSITUMOMAB I 131;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WART VIRUS VACCINE;
ACUTE HEART INFARCTION;
ANEMIA;
ARTICLE;
CELL STRAIN HEK293;
CEREBROVASCULAR ACCIDENT;
CHO CELL;
COLON CARCINOMA;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
DRUG MARKETING;
ESCHERICHIA COLI;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
GENOMICS;
HEMOPHILIA A;
HEPATITIS A;
HEPATITIS B;
HIGH THROUGHPUT SCREENING;
HUMAN;
HUNTER SYNDROME;
HURLER SYNDROME;
HYPERURICEMIA;
INFECTION;
INSULIN DEPENDENT DIABETES MELLITUS;
LUNG EMBOLISM;
MATURITY ONSET DIABETES MELLITUS;
MICROARRAY ANALYSIS;
MULTIPLE SCLEROSIS;
MYELOMA CELL;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
PROTEOMICS;
PSORIASIS VULGARIS;
RECTUM CARCINOMA;
RHEUMATOID ARTHRITIS;
SACCHAROMYCES CEREVISIAE;
SCHEIE SYNDROME;
VON WILLEBRAND DISEASE;
|
EID: 40549145848
PISSN: 10932607
EISSN: None
Source Type: Journal
DOI: 10.3233/hab-2007-163-408 Document Type: Article |
Times cited : (34)
|
References (9)
|